Yashodhara Dash is MSK’s Vice President of Technology Development and Commercialization. In October 2024, she was appointed to lead the Office of Technology Development, where her team includes business development and product development professionals, as well as an Operations and Finance unit. Together, they work on managing MSK intellectual property, supporting the development and commercialization of MSK technology, and promoting new company formation.

Yashodhara has supervised OTD’s Life Sciences, Digital Health, and Product Development groups since 2014, and she previously served as a Senior Licensing Manager. She joined MSK in 2007 as a Licensing Manager.

Yashodhara received her PhD degree in immunology from the University of Connecticut Health Center in 2007. Her educational background also includes an MBA degree from the University of Connecticut and an MBBS degree (with honors) from India’s SCB Medical College (an MBBS degree is equivalent to an MD degree).

Prior to joining Memorial Sloan Kettering, Yashodhara worked as a graduate research assistant at the University of Connecticut Health Center, where she successfully identified a protein antigen that is involved in the immune response against filariasis and may be used to formulate a protective vaccine. In India, she worked as a pediatric resident and medical intern with major rotations in the medicine, surgery, obstetrics, and gynecology wards.

She earned the Certified Licensing Professional (CLP) designation in 2012.

Yashodhara has taught an undergraduate seminar about drug development and the biotechnology industry, “The Economics and Science of Medicine,” at Yale University for the past eight years.